Records brain movement networks during deep brain stimulation surgery
Records brain activity during brain stimulation surgery in Parkinson disease or tremor.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Motor Network Physiology
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 18 Feb 2022
- Expected to end
- 1 Dec 2028
- Type of study
- Interventional
- Treatments tested
- Apomorphine Injectable Solution
- Subcortical Stimulation
- Record updated
- 1 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Parkinson's disease who have been advised to have deep brain stimulation surgery and can cooperate while awake during the operation.
- Age
- 18 Years to 89 Years
- Sex
- All sexes can join.
- Disease stage
- Parkinson's disease for which deep brain stimulation has been advised to treat the movement disorder.
- Earlier treatment
- No anticoagulant or antiplatelet medicine within one week before.
- Biomarker or test result
- Pre-surgery MRI with no cortical or subdural adhesions and no blood vessel abnormalities.
Main reasons for not taking part
- Recent use (within one week) of anticoagulant or antiplatelet medicine
- Memory-related (amnestic) cognitive deficits on thinking tests
- Unable or unwilling to cooperate while awake for up to 40 minutes of the operation
- Cortical or subdural adhesions or blood vessel abnormalities on pre-surgery MRI
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Diagnosis of Parkinson's disease who have been recommended to undergo deep brain stimulation for management of their movement disorder
- Preoperative MRI without evidence of cortical or subdural adhesions or vascular abnormalities
- Willingness and ability to cooperate during conscious operative procedure for up to 40 minutes
Who cannot take part
- Patients with recent use (within one week) of anticoagulant or antiplatelet agents
- Neurocognitive testing indicating amnestic cognitive deficits
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Where in United States
- UT Southwestern Medical CenterDallas, United StatesContact: Sahil ChilukuriTaking people
About the trial
What the trial wants to find out
The brain networks controlling movement are complex, involving multiple areas of the brain. Some neurological disorders, like Parkinson's disease (PD) and essential tremor (ET), cause abnormalities in these brain networks. Deep brain stimulation is a treatment that is used to treat these types of neurological diseases and is thought to help patients by modulating brain networks responsible for movement. Levodopa medication is also used to modulate this brain networks in patients with PD. The overall objective is to develop a unified theory of basal ganglia thalamocortical (BGTC) circuit dynamics that accounts for disease symptomatology, movement, and their inter-relationship. The underlying hypothesis, is that the rigidity and bradykinesia of PD are fundamentally related to excessive functional coupling across nodes in the BGTC motor circuit impeding effective information flow. In this research, the investigator will take advantage of the unique opportunity provided by awake deep brain stimulation surgery to learn more about how the brain functions in a diseased state and how deep brain stimulation changes these networks to make movement more normal. The investigator will simultaneously assess cortical and subcortical electrophysiology in relation to clinical symptoms and behavioral measures and in response to deep brain stimulation, cortical stimulation, and pharmacologic therapy in patients undergoing Deep Brain Stimulation (DBS) implantation surgery.
The group in the trial
- Parkinson's disease patientsTreatment being tested
This group consists of Parkinson's disease patients who are undergoing deep brain stimulation surgery for treatment of their movement disorder. Participants will complete behavioral assessments while receiving subcortical DBS stimulation and / or inhaled levodopa medication, Inbrija. Stimulation will be applied at the previously determined therapeutic frequency. Two capsules (84 mg) of Inbrija will be administered.
Treatment: Apomorphine Injectable Solution and Subcortical Stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Motor Network Physiology Characterization During Deep Brain Stimulation Surgery
- Plain-language title
- Records brain movement networks during deep brain stimulation surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04957095, who can take part
- Record updated
- 1 October 2026